Advertisement
News
Subscribe to MDT Magazine News

510(k) Final Decisions - June 2010(2)

July 7, 2010 10:31 am | by U.S. Food & Drug Administration | Comments

Page Last Updated: 07/07/2010 Note: If you need help accessing information in different file formats, see Instructions for Downlo

TOPICS:

510(k) Final Decisions - June 2010

July 7, 2010 10:30 am | Comments

Page Last Updated: 07/07/2010 Note: If you need help accessing information in different file formats, see Instructions for Downlo

Synageva gains orphan drug status for enzyme therapy

July 7, 2010 9:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Synageva BioPharma Corp. announced today that the U.S. Food and Drug Administration has granted the company orphan drug designation for its enzyme replacement therapy in development to treat Lysosomal Acid Lipase Deficiency.

Advertisement

Oramed Pharmaceuticals and sanofi-aventis Enter Into an Agreement for the Insulin Supply of Oramed's Oral Insulin Capsules

July 7, 2010 8:35 am | by Bio-Medicine.Org | Comments

JERUSALEM, Israel , July 7, 2010 /- Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) ( http://www.oramed.com ), a developer of oral delivery systems, today announced that Oramed entered into a Manufacturing Supply Agreement (MSA) with sanofi-aventis. According to the MSA, sanofi-aventis will...

TOPICS:

Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina

July 7, 2010 8:35 am | by Bio-Medicine.Org | Comments

NEW YORK , July 7 /- Reportlinker.com announces that a new market research report is available in its catalogue: Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina http://www.reportlinker.com/p0186217/Stakeholder-Opinions-Vaccines-in...

TOPICS:

Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity

July 7, 2010 8:34 am | by Bio-Medicine.Org | Comments

NEW YORK , July 7 /- Reportlinker.com announces that a new market research report is available in its catalogue: Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity http://www.reportlinker.com/p0...

TOPICS:

Renhuang Begins Trading on NYSE Amex

July 7, 2010 8:34 am | by Bio-Medicine.Org | Comments

HARBIN, China , July 7 /PRNewswire-Asia-FirstCall/ -- Renhuang Pharmaceuticals, Inc. (NYSE Amex: CBP ) ("Renhuang" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced that,...

TOPICS:

Ethicon, Inc. Expands Hemostasis Product Portfolio with Approval of the Company's First Synthetic Internal Use Sealant

July 7, 2010 8:33 am | by Bio-Medicine.Org | Comments

SOMERVILLE, N.J. , July 7 /- Ethicon, Inc., a worldwide leader in surgical care, announced today the introduction of ETHICON™ OMNEX™ Surgical Sealant, ETHICON™ Biosurgery's first synthetic sealant designed to achieve adjunctive hemostasis (stoppage of bleeding) in...

TOPICS:
Advertisement

Reprogrammed Herpes Virus Given Systemically Before Anti-vascular Drug Shrinks Distant Sarcomas

July 7, 2010 8:33 am | by Bio-Medicine.Org | Comments

CINCINNATI , July 7 /PRNewswire-USNewswire/ -- Scientists have used a genetically reprogrammed herpes virus and an anti-vascular drug to shrink spreading distant sarcomas designed to model metastatic disease in mice – still an elusive goal when treating humans with cancer, according...

TOPICS:

Genetically reprogrammed HSV given systemically shrinks distant sarcomas

July 7, 2010 7:37 am | by EurekAlert | Comments

(Cincinnati Children's Hospital Medical Center) Scientists have used a genetically reprogrammed herpes virus and an anti-vascular drug to shrink spreading distant sarcomas designed to model metastatic disease in mice -- still an elusive goal when treating humans with cancer,...

TOPICS:

Researchers demystifying complex cellular communications hubs found in sensory neurons

July 7, 2010 7:37 am | by EurekAlert | Comments

(American Society for Biochemistry and Molecular Biology) It's safe to say that cilia, the hairlike appendages jutting out from the smooth surfaces of most mammalian cells, have long been misunderstood -- underestimated, even.

TOPICS:

Frontiers in Cardiovascular Biology: July 16-19, 2010, Berlin, Germany

July 7, 2010 7:37 am | by EurekAlert | Comments

(European Society of Cardiology) Frontiers in Cardiovascular Biology, the first scientific meeting ever organized by the Council on Basic Cardiovascular Science of the European Society of Cardiology, is being held in Berlin this month to provide a new European platform for the...

TOPICS:

Draper working on inner ear drug delivery device

July 7, 2010 7:37 am | by I-Micronews | Comments

Draper Laboratory from Cambridge, MA, is developing a new implantable device that can deliver drugs right to the inner ear.

Bio2 takes $1M for orthopedic materials tech

July 7, 2010 7:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Woburn medical device firm Bio2 Technologies Inc. has taken in $1.1 million in equity financing. The company makes tissue engineering scaffolds, intended for orthopedic use.

Hospital study suggests that early transfusion increases acute upper GI re-bleeding risk

July 7, 2010 7:34 am | by EurekAlert | Comments

(Wiley-Blackwell) Doctors have called for an urgent review of transfusion policies after a UK-wide study of 221 hospitals found that patients admitted with acute upper gastrointestinal bleeding are more than twice as likely to suffer further bleeding if they receive a red blood...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading